BioWorld

Oct. 15, 2004

View Archived Issues

New Horizons For Flu Seed Strain, Vaccine Production

Read More

Gloucester $29M Round To Put FK228 Into Pivotal Study

Read More

Other News To Note

Read More

Chiron Files Pulminiq NDA As Feds Probe Flu Vaccine Miscue

Releasing a bit of good news, Chiron Corp. submitted a new drug application for Pulminiq inhalation solution for lung transplant patients. (BioWorld Today) Read More

Lawyer: Advisory Panels 'Black Hole,' 505 Option Jeopardized

Read More